Generic Health Pty Ltd secures investment from Lupin Limited

Melbourne, Australia August 25, 2008;

Generic Health Pty Ltd, an Australian owned and operated generic pharmaceutical company headquartered in Melbourne, Australia, has today announced that it has secured a strategic investment from Lupin Limited which is among the top five pharmaceutical companies in India and a significant global supplier.

Since its formation in 2004,Generic Health has been providing quality generic medicines to the Australian market via highly competitive and sustainable partnerships. Generic Health is well advanced in its plans to become a significant player in the Australian generics pharmaceutical industry. This announcement follows on from Generic Health’s recently announced partnership with Actavis in June this year and the acquisition of Bellwether Pharma in 2007.

Lupin’s investment complements existing supply arrangements for a number of products with a total market size exceeding A$800m. “Lupin’s equity investment will result in no change in the day-to-day operations of Generic Health” and our customers will benefit significantly from greater resources and access to competitive products.” said Gavin Upiter Managing Director, Generic Health.

Commenting on the development Mr. Vinod Dhawan, Regional President, Lupin Limited said. “Our investment in Generic Health reflects our commitment to expand our business in Australia. We have built a significant business in this market leveraging our existing alliances with leading local generic companies which we will continue to nurture and grow.”

“The new investment arrangement with Lupin will support our longer term market share ambitions and contribute to our long term growth strategy, market supply and range of pharmaceutical products in the Australian market.” said Generic Health Managing Director, Gavin Upiter.

------------------------------------------

About Generic Health

Generic Health Pty Ltd is a privately held, fast growing Australian owned and operated pharmaceutical company, marketing, selling and distributing a range of generic pharmaceutical prescription and OTC medications. Generic Health’s strategic focus has been on delivering low cost, high quality products linked to simplified and transparent transactions. Generic Health was founded in 2004 by Mr Gavin Upiter.

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs for the advanced and emerging markets of the world.

The Company has secured global leadership position in Anti-TB and Cephalosporin’s and has a significant presence in the areas of Cardiovasculars (prils and statins), Diabetology, Asthma and NSAIDs. The Company’s R&D endeavours have resulted in significant progress in its NCE program. The Company’s foray into Advanced Drug Delivery Systems has resulted in the development of platform technologies that are being used to develop value-added generic pharmaceuticals.

Currently positioned amongst the top five pharmaceutical companies of India, the Company is committed to achieve sustainable earnings and growth for all its stakeholders. For the financial year ended March 2008, the Lupin's Revenues and Profit after Tax were Rs.27,730 million (US$ 694 million) and Rs.4,083 million (US$ 102 million) respectively.

For more information, visit http://www.lupinworld.com